68,833 Shares in AVANOS MEDICAL, INC. (NYSE:AVNS) Bought by Easterly Investment Partners LLC

Easterly Investment Partners LLC purchased a new stake in AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 68,833 shares of the company's stock, valued at approximately $986,000. Easterly Investment Partners LLC owned 0.15% of AVANOS MEDICAL as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of AVNS. GAMMA Investing LLC grew its holdings in AVANOS MEDICAL by 2,381.6% during the first quarter. GAMMA Investing LLC now owns 17,024 shares of the company's stock worth $244,000 after buying an additional 16,338 shares in the last quarter. Bank of America Corp DE boosted its holdings in AVANOS MEDICAL by 2.5% during the 4th quarter. Bank of America Corp DE now owns 63,672 shares of the company's stock worth $1,014,000 after acquiring an additional 1,537 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of AVANOS MEDICAL by 2.6% in the first quarter. Principal Financial Group Inc. now owns 244,063 shares of the company's stock valued at $3,497,000 after purchasing an additional 6,269 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of AVANOS MEDICAL by 15.8% during the fourth quarter. Envestnet Asset Management Inc. now owns 128,567 shares of the company's stock valued at $2,047,000 after purchasing an additional 17,504 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in AVANOS MEDICAL by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 5,339,778 shares of the company's stock worth $85,009,000 after purchasing an additional 19,476 shares during the last quarter. Institutional investors and hedge funds own 95.17% of the company's stock.

AVANOS MEDICAL Price Performance

NYSE:AVNS traded up $0.18 during mid-day trading on Monday, hitting $11.40. 438,580 shares of the stock traded hands, compared to its average volume of 393,090. The business's 50-day moving average price is $12.32 and its 200 day moving average price is $13.84. The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 0.12. The company has a market cap of $527.14 million, a PE ratio of -1.36 and a beta of 1.12. AVANOS MEDICAL, INC. has a 12-month low of $11.21 and a 12-month high of $25.36.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. The company had revenue of $167.50 million for the quarter, compared to the consensus estimate of $161.75 million. During the same quarter in the previous year, the business earned $0.22 EPS. AVANOS MEDICAL's revenue was up .8% compared to the same quarter last year. On average, analysts expect that AVANOS MEDICAL, INC. will post 1.32 EPS for the current fiscal year.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.